查看文章

NE, TG, MKK, GMC, JMT and HR are shareholders in and/or employees of Helix Nanotechnologies Inc., which is developing gene-encoded vaccines for SARS-CoV-2. A full list of GMC’s technology transfer, advisory roles and funding sources can be found at http://arep. med. harvard. edu/gmc/tech. html. JMT is a shareholder and employee of SmartPharm Therapeutics, which is developing gene-encoded antibody vaccines for SARS-CoV-2.